Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Autism Services Provider Goes to Golden Gate Capital
Another private equity firm has thrown its hat in the autism ring. Golden Gate Capital announced its acquisition of Invo Holdings, LLC from The Jordan Company. The Jordan Company and Invo’s management will retain minority ownership stakes in the business. Invo Holdings, based in Jamison, Pennsylvania, provides a range of multi-disciplinary, research-based therapy services to infants, toddlers and school-aged children with various developmental delays, including autism, in homes, at schools and in community-based centers across 27 states. It 2,500 clinicians include board-certified behavior analysts, registered behavioral technicians, speech-language pathologists, occupational and... Read More »
St. Christopher’s Hospital Goes to Auction in Philly
Yet another hospital bankruptcy has led to an auction and a sale. This time it was St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. The 188-bed hospital is a healthcare outpost in north Philly and one of only two children’s hospitals in the city. In 2018 it and Hahnemann University Hospital were sold by Tenet Healthcare (NYSE: THC) to California investment banker Joel Freedman, represented as American Academic Health Systems LLC (AAHS), for $170 million. Hahnemann’s financial troubles prompted American Academic to file for Chapter 11 bankruptcy protection on June 30 and led to that hospital’s closure in July 2019. St. Christopher’s... Read More »
TPG Capital Re-enters the Southeast Asia Hospital Market
TPG Capital and its sponsored companies have been on a tear in 2019. Through its recently launched U.S. autism platform, Kadiant, the global private equity firm announced six deals since February. Its U.S.-based digital health company WellSky announced two deals in the past 12 months and back in February, Kindred Healthcare, now co-owned by TPG and Welsh, Carson, Anderson & Stowe, acquired a hospital in Los Angeles out of the Promise Healthcare bankruptcy. In early September, TPG announced its acquisition of another digital health company, Convey Health Solutions, from New Mountain Capital for an undisclosed price. Two weeks later, the firm was back in the news with a $1.2 billion deal... Read More »
Alder BioPharmaceuticals Merges with H. Lundbeck in $1.95 Billion Deal
H. Lundbeck A/S (OMX: LUN), the specialty pharmaceutical giant based in Denmark, announced its first acquisition in over a year. The company revealed it was buying Alder BioPharmaceuticals (NASDAQ: ALDR), a clinical-stage biopharmaceutical company focused on transforming migraine treatment through the discovery, development and commercialization of novel therapeutic antibodies. One product candidate is ALD1910, a monoclonal antibody for migraine prevention. Lundbeck gains Alder’s eptinezumab product, an investigational monoclonal antibody for migraine prevention that it will develop and launch worldwide in the upcoming years. Lundbeck expects to see significant growth in its brain... Read More »
EyeCare Partners Grows Its National Platform
EyeCare Partners’ acquisition marathon shows no signs of slowing down. Ever since FFL Partners formed the group with the acquisition of Clarkson Eyecare in April 2015, EyeCare Partners (ECP) has expanded rapidly, consolidating smaller firms to grow a national network. Last week, the group purchased Nationwide Vision from Refac Optical Group, a portfolio company of Acon Investments. Nationwide is a full-service vision care provider operating 89 optometry offices throughout Arizona and Florida. This acquisition brings EyeCare Partners’ network range to up to 450 locations nationwide. No financial terms were disclosed. Earlier in September, ECP acquired Associated Retinal... Read More »
Health Care M&A Deals, Week Ending September 20, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price H. Lundbeck A/S Alder BioPharmaceuticals $1,950,000,000 eHealth Acquirer Target Price HMS Holdings Corp. VitreosHealth $36,500,000 Labs, MRI & Dialysis Acquirer Target Price Praesidian Capital Genetics business Long-Term Care... Read More »
OptimizeRx Grows Patient Communication Platform with RMDY Acquisition
OptimizeRx (NYSE: OPRX), a digital patient communication company, ramped up its platform last week with the acquisition of RMDY Health for $16 million. RMDY offers a SaaS platform that provides a complete digital framework to help life science and healthcare stakeholders design and launch their own white-label collaborative digital care and patient support programs. The company’s web and mobile platform supports a wide range of digital therapeutic initiatives, with a focus on care and chronic disease management, among others. For 2019, the company has an estimated annual revenue of $3 million. The acquisition adds three new client segments to OptimizeRx’s existing patient... Read More »
Health Care M&A Deals, Week Ending September 13, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Generex Biotechnology Corporation ALTuCELL, Inc. N/A Alexion Pharmaceuticals, Inc. Exclusive license to AG10 $50,000,000 Flexion Therapeutics, Inc. Rights to XEN402 $3,000,000 GlaxoSmithKline plc Sitari Pharmaceuticals N/A eHealth Acquirer Target... Read More »
